32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics Series A expected to advance lead asset Mucosal-Immune Modulator CS-0003 through ...
The bar for a mainstream projector went way up this year, thanks to an invasion of high-quality laser projectors. My pick for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results